Axogen, Inc. Investing Cash Flow
Axogen, Inc. (AXGN) reported Investing Cash Flow of -$15.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-29
- Axogen, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $500.00K.
- Axogen, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$15.96M, a 1292.23% decline year-over-year.
- Axogen, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $4.04M.
- Axogen, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$3.75M.
- Axogen, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$5.32M.
- Axogen, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$10.30M, a 153.48% decline from fiscal 2023.
- Axogen, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $19.25M.
- Axogen, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$3.20M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$15.46M 10-Q · filed 2026-07-29 | -$11.42M derived: sum of 3 quarters · filed 2026-07-29 | -$15.17M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | -$15.96M 10-Q · filed 2026-04-28 | -$11.92M derived: sum of 2 quarters · filed 2026-04-28 | -$15.67M derived: sum of 3 quarters · filed 2026-04-28 | -$22.62M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $291.00K derived: sum of 2 quarters · filed 2026-02-24 | -$6.66M derived: sum of 3 quarters · filed 2026-07-29 | -$5.32M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$10.70M derived: sum of 2 quarters · filed 2026-07-29 | -$9.36M 10-Q · filed 2025-10-29 | -$10.17M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$6.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$5.61M 10-Q · filed 2026-07-29 | -$6.42M derived: sum of 3 quarters · filed 2026-07-29 | -$11.42M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $1.34M 10-Q · filed 2026-04-28 | $526.00K derived: sum of 2 quarters · filed 2026-04-28 | -$4.47M derived: sum of 3 quarters · filed 2026-04-28 | -$5.71M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | -$813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.81M derived: sum of 2 quarters · filed 2026-02-24 | -$7.05M derived: sum of 3 quarters · filed 2026-02-24 | -$10.30M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$6.23M derived: sum of 2 quarters · filed 2025-10-29 | -$9.48M 10-Q · filed 2025-10-29 | -$9.76M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$4.48M 10-Q · filed 2025-08-05 | -$4.76M derived: sum of 3 quarters · filed 2026-02-24 | $1.23M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$3.25M 10-Q · filed 2025-05-08 | -$3.53M derived: sum of 2 quarters · filed 2026-02-24 | $2.47M derived: sum of 3 quarters · filed 2026-02-24 | $16.79M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.72M derived: sum of 2 quarters · filed 2026-02-24 | $20.04M derived: sum of 3 quarters · filed 2026-02-24 | $19.25M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $5.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $20.32M derived: sum of 2 quarters · filed 2024-11-07 | $19.53M 10-Q · filed 2024-11-07 | $18.32M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $14.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $13.54M 10-Q · filed 2024-08-08 | $12.33M derived: sum of 3 quarters · filed 2025-02-26 | $15.30M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | -$786.00K 10-Q · filed 2024-05-02 | -$2.00M derived: sum of 2 quarters · filed 2025-02-26 | $976.00K derived: sum of 3 quarters · filed 2025-02-26 | $3.25M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.76M derived: sum of 2 quarters · filed 2025-02-26 | $4.04M derived: sum of 3 quarters · filed 2025-02-26 | -$3.20M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $5.25M derived: sum of 2 quarters · filed 2023-11-07 | -$1.99M 10-Q · filed 2023-11-07 | -$15.58M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.96M 10-Q · filed 2023-08-08 | -$18.55M derived: sum of 3 quarters · filed 2024-03-05 | -$25.32M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | -$7.24M 10-Q · filed 2023-05-09 | -$20.83M derived: sum of 2 quarters · filed 2024-03-05 | -$27.60M derived: sum of 3 quarters · filed 2024-03-05 | -$31.76M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | -$13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$20.36M derived: sum of 2 quarters · filed 2024-03-05 | -$24.52M derived: sum of 3 quarters · filed 2024-03-05 | -$23.65M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | -$6.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$10.93M derived: sum of 2 quarters · filed 2022-11-08 | -$10.06M 10-Q · filed 2022-11-08 | -$29.42M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-06-30 | -$4.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$3.29M 10-Q · filed 2022-08-05 | -$22.64M derived: sum of 3 quarters · filed 2023-03-14 | -$43.77M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-03-31 | $870.00K 10-Q · filed 2022-05-05 | -$18.48M derived: sum of 2 quarters · filed 2023-03-14 | -$39.61M derived: sum of 3 quarters · filed 2023-03-14 | -$24.64M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2020-12-31 | -$19.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$40.48M derived: sum of 2 quarters · filed 2023-03-14 | -$25.51M derived: sum of 3 quarters · filed 2023-03-14 | -$16.96M 10-K · filed 2023-03-14 | ||||
| 2020-09-30 | -$21.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$6.16M derived: sum of 2 quarters · filed 2021-11-04 | $2.39M 10-Q · filed 2021-11-04 | $15.97M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $14.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $23.52M 10-Q · filed 2021-08-05 | $37.10M derived: sum of 3 quarters · filed 2022-02-25 | $38.03M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $8.55M 10-Q · filed 2021-05-06 | $22.14M derived: sum of 2 quarters · filed 2022-02-25 | $23.06M derived: sum of 3 quarters · filed 2022-02-25 | $28.05M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $14.51M derived: sum of 2 quarters · filed 2022-02-25 | $19.50M derived: sum of 3 quarters · filed 2022-02-25 | $27.27M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $921.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $5.92M derived: sum of 2 quarters · filed 2020-10-30 | $13.69M 10-Q · filed 2020-10-30 | $22.23M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $12.76M 10-Q · filed 2020-08-07 | $21.31M derived: sum of 3 quarters · filed 2021-03-01 | -$84.52M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $7.77M 10-Q · filed 2020-05-06 | $16.31M derived: sum of 2 quarters · filed 2021-03-01 | -$89.51M derived: sum of 3 quarters · filed 2021-03-01 | -$89.92M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $8.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$97.28M derived: sum of 2 quarters · filed 2021-03-01 | -$97.69M derived: sum of 3 quarters · filed 2021-03-01 | -$98.19M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$105.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$106.24M derived: sum of 2 quarters · filed 2019-11-06 | -$106.74M 10-Q · filed 2019-11-06 | -$106.74M 10-Q · filed 2018-10-29 | -$107.23M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | -$413.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$914.00K 10-Q · filed 2019-08-06 | -$913.92K 10-Q · filed 2018-08-01 | -$1.41M derived: sum of 3 quarters · filed 2020-02-24 | -$1.69M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | -$501.00K 10-Q · filed 2019-05-08 | -$501.18K 10-Q · filed 2018-04-30 | -$993.62K derived: sum of 2 quarters · filed 2020-02-24 | -$1.27M derived: sum of 3 quarters · filed 2020-02-24 | -$1.61M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | -$492.62K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$771.79K derived: sum of 2 quarters · filed 2020-02-24 | -$1.11M derived: sum of 3 quarters · filed 2020-02-24 | -$1.29M 10-K · filed 2020-02-24 | -$1.29M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | -$279.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | -$616.10K derived: sum of 2 quarters · filed 2018-10-29 | -$799.38K 10-Q · filed 2018-10-29 | -$1.19M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$336.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$520.21K 10-Q · filed 2018-08-01 | -$906.74K derived: sum of 3 quarters · filed 2019-02-26 | |||||
| 2017-03-31 | -$183.29K 10-Q · filed 2018-04-30 | -$569.82K derived: sum of 2 quarters · filed 2019-02-26 | ||||||
| 2016-12-31 | -$386.54K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$1.16M 10-K · filed 2019-02-26 | -$1.16M 10-K · filed 2018-02-28 | |||||
| 2016-09-30 | -$770.47K 10-Q · filed 2017-11-01 | |||||||
| 2015-12-31 | -$555.52K 10-K · filed 2018-02-28 | |||||||
| 2013-09-30 | -$32.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$59.40K derived: sum of 2 quarters · filed 2013-10-30 | -$116.83K 10-Q · filed 2013-10-30 | -$124.39K derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2013-06-30 | -$26.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$84.38K 10-Q · filed 2013-08-14 | -$91.94K derived: sum of 3 quarters · filed 2013-08-14 | -$131.49K derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2013-03-31 | -$57.42K 10-Q · filed 2013-04-30 | -$64.98K derived: sum of 2 quarters · filed 2013-08-07 | -$104.54K derived: sum of 3 quarters · filed 2013-10-30 | -$114.16K derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2012-12-31 | -$7.56K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | -$47.12K derived: sum of 2 quarters · filed 2013-10-30 | -$56.73K derived: sum of 3 quarters · filed 2013-10-30 | -$127.28K 10-K/A · filed 2013-08-07 | ||||
| 2012-09-30 | -$39.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$49.17K derived: sum of 2 quarters · filed 2013-10-30 | -$119.72K 10-Q · filed 2013-10-30 | -$155.88K derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2012-06-30 | -$9.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$80.17K 10-Q · filed 2013-08-14 | -$116.32K derived: sum of 3 quarters · filed 2013-08-14 | $7.06M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | -$70.55K 10-Q · filed 2013-04-30 | -$106.70K derived: sum of 2 quarters · filed 2013-08-07 | $7.07M derived: sum of 3 quarters · filed 2013-08-07 | $7.06M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-12-31 | -$36.15K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $7.14M derived: sum of 2 quarters · filed 2013-08-07 | $7.13M derived: sum of 3 quarters · filed 2013-08-07 | $7.11M 10-K/A · filed 2013-08-07 | ||||
| 2011-09-30 | $7.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $7.17M derived: sum of 2 quarters · filed 2012-11-06 | $7.15M 10-Q · filed 2012-11-06 | $7.13M derived: sum of 4 quarters · filed 2012-11-06 | ||||
| 2011-06-30 | -$7.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$25.55K 10-Q · filed 2012-08-14 | -$2.26M 10-Q/A · filed 2011-09-09 | -$40.30K derived: sum of 3 quarters · filed 2012-08-14 | -$88.57K derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | -$17.98K 10-Q · filed 2012-05-15 | -$32.73K derived: sum of 2 quarters · filed 2012-05-15 | -$81.00K derived: sum of 3 quarters · filed 2012-05-15 | |||||
| 2010-12-31 | -$14.75K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | -$63.02K derived: sum of 2 quarters · filed 2012-03-15 | -$72.00K 10-K · filed 2012-03-15 | |||||
| 2010-09-30 | -$48.27K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$57.26K 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$8.99K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |